医药信用评价制度或将更新，企业失信企业如何应对“天价”惩罚

Core Viewpoint - The National Medical Insurance Administration (NMI) is set to release a new version of the medical pricing and procurement credit evaluation system, which aims to strengthen regulation in the pharmaceutical industry and address issues such as commercial bribery and tax violations [1][3]. Summary by Sections Regulatory Changes - The new system will adjust the current rating categories from four to three, changing "general," "medium," "serious," and "particularly serious" to "discredited," "seriously discredited," and "particularly seriously discredited" [3]. - The threshold for "particularly serious discredited" ratings will be lowered, enhancing the punitive measures against companies involved in bribery and fraudulent activities [3][4]. Industry Impact - The number of discredited companies has been increasing, with 735 companies identified by the end of 2024, indicating a growing trend of accountability within the industry [1][6]. - The revised system may restrict companies rated as "medium" or higher from participating in large procurement projects, potentially leading to significant financial implications [4][6]. Responsibility and Accountability - There is ongoing debate regarding whether production companies should bear responsibility for the misconduct of their distributors, with experts suggesting that companies must implement reasonable oversight and management of their distributors [2][7]. - The case of Yuheng Pharmaceutical, which was rated "seriously discredited" due to bribery by a distributor, highlights the complexities of accountability within the supply chain [7][8]. Administrative Penalties - The integration of administrative penalties into the credit evaluation process is being considered, with the aim of creating a more cohesive regulatory framework [9][10]. - Current practices show a lack of direct correlation between administrative penalties and credit ratings, indicating a need for improved mechanisms to ensure accountability [9][10]. Credit Repair Mechanisms - A "pre-repair" mechanism is being explored, allowing companies to correct issues before formal ratings are assigned, which could lead to more proactive compliance [10]. - Companies can undertake various actions to restore their credit ratings, such as terminating discredited practices, submitting compliance reports, and engaging in public welfare activities [10].